Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.
about
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.The proteasome and proteasome inhibitors in multiple myeloma.An overview of the role of carfilzomib in the treatment of multiple myeloma.Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline Therapy.Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma CellsPterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells
P2860
Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@en
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@nl
type
label
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@en
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@nl
prefLabel
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@en
Carfilzomib resistance due to ...... lopinavir in multiple myeloma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Carfilzomib resistance due to ...... lopinavir in multiple myeloma
@en
P2093
H S Overkleeft
N Weinhold
P2860
P2888
P304
P356
10.1038/LEU.2017.212
P577
2017-07-05T00:00:00Z